- Home
- CMMB vs PRHI Comparison
CMMB vs PRHI Comparison
Compare CMMB & PRHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMMB | PRHI |
|---|---|---|
| Founded | 2004 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 9.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | CMMB | PRHI |
|---|---|---|
| Price | $1.86 | $0.71 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $25.00 | N/A |
| AVG Volume (30 Days) | ★ 73.0K | 54.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 101.67 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $25.91 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.75 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.87 | $0.50 |
| 52 Week High | $3.86 | $2.83 |
Technical Indicators
Market Signals| Indicator | CMMB | PRHI |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 48.61 |
| Support Level | $1.48 | $0.63 |
| Resistance Level | $1.85 | $0.87 |
| Average True Range (ATR) | 0.19 | 0.06 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 61.26 | 27.88 |
Price Performance
Historical ComparisonAbout CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About PRHI Presurance Holdings Inc.
Presurance Holdings Inc Formerly Conifer Holdings Inc is an insurance holding company. The company markets and services the product offerings of the company through specialty personal insurance business lines. The company offers insurance products in Texas, Illinois, and Indiana for homeowners lines and Nevada and Michigan for other lines. The revenues of the company are derived from premiums earned from insurance operations.